18:02 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Ltd
- Share price
- ₹101.46
- Market cap
- ₹161.5 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 22.4×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 6Management Change 4Financial Results 3Capital Structure Change 3Dividend 2Board Meeting Date 2Price Movement Clarification 1Merger & Restructuring 1Legal & Regulatory 1Fund Raise 1Annual Report 1
Time
4 announcements with these filters
18:38 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced changes in director designations, effective October 1, 2026. These changes were approved during the board meeting held on August 12, 2026.
16:41 IST
BSE
Management Change
Bal Pharma Management Change
Mr. Shreepada ML has commenced duties as Company Secretary and Compliance Officer. The appointment is effective from June 23, 2026.
11:27 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma announced the resignation of Company Secretary and Compliance Officer Mr. Abdul Basith. He was relieved from services effective May 11, 2026.